Icon Group has been named a finalist in the 2016 Aspire Awards presented by Financial Review and PwC’s Private Clients’ division. The awards recognise the best of Australia’s private and family businesses, highlighting outstanding organisations that shape our economy and society.
Icon Group has been named a finalist in the highly competitive Private Business Growth and Transformation category, which recognises businesses that have successfully:
- transformed themselves in order to grow
- adapted to changing environment/demands or
- had sustainable growth over time
Mark Middleton, Icon Group CEO, said “This announcement is another confirmation of our commitment to patients, and the positive impact we are having on the healthcare industry and society. Over the last two years we have evolved from a day oncology hospital to deliver a full profile of cancer care services including medical oncology, haematology, radiation oncology, pharmacy and chemotherapy compounding. The result is an integrated cancer care model that is committed to supporting patients through every step of their treatment.”
For a full list of finalist click here. Winners will be announced at an awards presentation in Sydney on 9 November 2016.